The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.
about
Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial diseaseSpatiotemporal Changes Posttreatment in Peripheral Arterial DiseaseMitochondrial Regulation of the Muscle Microenvironment in Critical Limb IschemiaLower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemiaDespite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient miceOptical probing of gastrocnemius in patients with peripheral artery disease characterizes myopathic biochemical alterations and correlates with stage of disease.LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and mortality?Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot studyMultifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism.A functional murine model of hindlimb demand ischemia.Greater endothelial apoptosis and oxidative stress in patients with peripheral artery diseaseCrossroads between peripheral atherosclerosis, western-type diet and skeletal muscle pathophysiology: emphasis on apolipoprotein E deficiency and peripheral arterial disease.Abnormal joint powers before and after the onset of claudication symptoms.Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective.Gender and racial differences in endothelial oxidative stress and inflammation in patients with symptomatic peripheral artery disease.Surface-enhanced Raman spectral biomarkers correlate with Ankle Brachial Index and characterize leg muscle biochemical composition of patients with peripheral arterial disease.Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.Muscle cell derived angiopoietin-1 contributes to both myogenesis and angiogenesis in the ischemic environment.A review of the pathophysiology and potential biomarkers for peripheral artery disease.Abnormal myofiber morphology and limb dysfunction in claudication.External work is deficient in both limbs of patients with unilateral PADTransforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease.Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage.From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.Morphometric analysis of gastrocnemius muscle biopsies from patients with peripheral arterial disease: objective grading of muscle degeneration.Genetics of peripheral artery diseaseExercise training and peripheral arterial disease.Gastrocnemius mitochondrial respiration: are there any differences between men and women?Human enterovirus in the gastrocnemius of patients with peripheral arterial disease.Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication.Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease.Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T-cell polarization during early and late stagesMitochondrial Bioenergetics in the Metabolic Myopathy Accompanying Peripheral Artery Disease.Lower Mitochondrial Energy Production of the Thigh Muscles in Patients With Low-Normal Ankle-Brachial Index.Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.Medical Therapy in Peripheral Artery Disease and Critical Limb Ischemia.Lumbar sympathectomy techniques for critical lower limb ischaemia due to non-reconstructable peripheral arterial disease.Development of an in vitro model of myotube ischemia.Impact of a single session of intermittent pneumatic leg compressions on skeletal muscle and isolated artery gene expression in rats.
P2860
Q24186303-F2C3A6FC-BF44-4DFA-9A83-5C3F19A4BC4CQ26771791-389C2C5E-52A0-47E4-93A3-EDB2D255E137Q26774784-C744E1B4-BC1A-4A45-9F64-8783C9D381E0Q28084776-DBECFB49-A1FA-4F83-B6E9-F644F72338A8Q30358598-17CE4591-792F-4313-804C-BE96FE1077D1Q30360841-8600AE14-1558-4C3D-8B0C-9A45CFE8F472Q30422549-140D555F-F023-4D5E-82A9-0D29F28A0504Q30427822-7BB851CC-641C-4C59-9D1A-BB645758302AQ30435144-FC74ED23-B5E8-42BC-B949-1894E463697FQ33549031-11AC4139-C06A-4677-8494-81D673A846DBQ33745594-FC8343E0-0D05-4128-8DE6-A91D51A4D97BQ33885504-FC54056C-07E4-4621-A5A5-CE7EB3DAF2E4Q34066383-9EACEEEB-F2DD-4389-BC45-1E6FF01B5153Q34085963-2E52108B-F2C4-4630-99CC-F5EF403CE43BQ34288235-CA94710B-B55A-41D7-9139-8CBAEBA87718Q34730585-775D31CA-BDB5-4072-A850-175F6E0922DBQ35217900-9189C189-32C7-4D19-B4A1-64239D0AC627Q35621136-C3DB6E70-7EDB-45F8-A6B3-8EAB2A960483Q35723731-870D6105-174F-4235-965B-AE5521E92115Q35882665-6F769071-CFA1-4EDC-84D6-82129404781EQ35990250-0D18C122-42B6-4751-BC69-33A4C88B279CQ36549555-47C4CC80-DDA8-4CC8-9ECA-FC298A9887F9Q36808114-57D80BC1-20FF-4FCB-84E7-131059A12B96Q36923569-4696432F-F280-4FDE-B47C-E5A3539B258DQ37094150-7DBECC03-727C-44FF-BB9A-A6E24DB54651Q37127078-9D23CB07-E616-4DDB-B71A-A4360F6669D6Q37157213-C1DA2CE0-D1E7-4B39-AC36-63CC29DD59E1Q37248528-26268417-D797-44EF-BA02-3CC630F33326Q37310417-CBE7DB4D-3686-406A-8184-EF0315B88691Q37344502-4B8DF9C5-BCE8-4F11-8AE6-FEF2E0C0F520Q37361610-374FF5C0-8283-49EB-9EC8-08C028393876Q37664155-B3C66B8E-CFDC-4163-BDFF-3BE405863553Q37694486-923B675C-4368-4C1D-8150-E0DB6F51F3A5Q38601748-AB29D311-09A9-4130-864E-D68B7E808046Q38799483-939F7912-2E4B-49B1-B70F-5B60FE4D3EDCQ38807921-812AEF73-AA9C-4D9B-8421-AE7ACF127A6AQ38834990-AE3644DC-1F37-453A-802F-FE6006F6FB3CQ39037401-1F3CFDDE-9DF6-44E0-BDB7-C2C17F77803AQ39537577-C7704B1C-3252-4ADB-92CE-48D02671ECC8Q39685421-C48C193F-9B31-4097-A566-3E0CD6B40152
P2860
The myopathy of peripheral arterial occlusive disease: part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The myopathy of peripheral art ...... for mitochondrial dysfunction.
@en
The myopathy of peripheral art ...... for mitochondrial dysfunction.
@nl
type
label
The myopathy of peripheral art ...... for mitochondrial dysfunction.
@en
The myopathy of peripheral art ...... for mitochondrial dysfunction.
@nl
prefLabel
The myopathy of peripheral art ...... for mitochondrial dysfunction.
@en
The myopathy of peripheral art ...... for mitochondrial dysfunction.
@nl
P2093
P356
P1476
The myopathy of peripheral art ...... for mitochondrial dysfunction.
@en
P2093
Aikaterini A Nella
Andrew R Judge
Iraklis I Pipinos
Joshua T Selsby
Stanley A Swanson
Stephen L Dodd
P304
P356
10.1177/1538574407311106
P577
2007-12-01T00:00:00Z